Expert Radar
Dr. Mingyi Chen, MD, PhD
Dr. Mingyi Chen, MD, PhD
Professor, UT Southwestern Medical Center (Dallas, TX)
Doctor of Philosophy, Kyoto University
Dr. Mingyi M. Chen has specialized experience in the fields of Hematology, Hematology & Oncology, Health Education, and Pathology. They earned their MD from Beijing Medical University and their PhD in Pharmacology from Kyoto University. After completing their residency in Pathology at Loma Linda University School of Medicine, they went on to complete a fellowship in Pathology and Laboratory Medicine at UCLA Santa Monica Medical Center. Today, the expert holds certifications in Hematopathology and Pathology - Anatomic/Pathology - Clinical. Previously, they held the role of Associate Medical Director at Shriners Healthcare for Children. Currently, they work as a Professor at UT Southwestern Medical Center and Medical Director at Moncrief Cancer Institute.
m*********@******.edu
(214) ***-****
Dallas, Texas
Get a FREE Demo of Dr. Mingyi Chen, MD, PhD's Radar Profile
Review this expert's litigation history, supporting legal docs, publications, professional background, and more.
Comprehensive data on expert witnesses: Access detailed litigation history and performance metrics.
Swift assessment: Quickly evaluate an expert's track record.
Informed decisions: Make better choices when selecting or challenging expert witnesses in any case.
DISCLAIMER: Expert Institute operates independently and objectively as an expert witness data provider. This listing does not reflect or imply any existing relationship between the expert and Expert Institute. We do not employ, endorse, or maintain any affiliation with the experts listed. Information shown is automatically generated from public sources and may not be current or complete. For verified, in-depth expert data, please contact us to initiate a formal request.
Radar Metrics At A Glance
Expert Witness Activity
Plaintiff Cases
Defense Cases
Expert Challenges
Deposition Transcripts
Publications
144
Media & News
228
Social Media Mentions
Expert Witness Activity
Case Name | Role | Filed Date |
|---|
Unlock Dr. Mingyi Chen, MD, PhD's full profile
Litigation Analytics
Retained By
Defense
Plaintiff
Activity over time
0
25
50
75
100
2000
0
2002
0
2004
0
2006
0
2008
0
2010
0
Activity by state
Case Outcome
0
25
50
75
100
Education
Institution | Degree Type |
|---|---|
Kyoto University | Doctor of Philosophy |
— | Doctor of Medicine |
Work History
Title | Employer |
|---|---|
Professor | UT Southwestern Medical Center (Dallas, TX) |
Medical Director | Moncrief Cancer Institute |
— | University of California, San Diego |
Publications
Radar found 144 records
Title | Type |
|---|---|
B/T mixed phenotype acute leukemia revealing immunophenotypic lineage-genotype associations and frequent myelodysplasia-related cytogenetic/gene abnormalities: implication for diagnosis and treatment | Journal Article |
HCB101: a novel potent ligand-trap Fc-fusion protein targeting the CD47-SIRPα pathway with high safety and preclinical efficacy for hematological and solid tumors | Letter |
TAp63γ is the primary isoform of TP63 for tumor suppression but not development | Journal Article |
Radar monitors a wide array of publication sources, including links to abstracts.
Review book chapters, journal articles, research papers, trade publications, technical reports, conference proceedings, and more.
Media & News
Radar found 228 records
Title | Description |
|---|
Unlock Dr. Mingyi Chen, MD, PhD's full profile
Radar scours thousands of media and news sources across the internet 24/7.
Access interviews, webinars, TV appearances, blog posts, columns, whitepapers, PDFs, profressional profiles, and more.
What to expect from a Radar profile
Access detailed litigation history and performance metrics.
Access your Radar profile through Expert iQ, our secure, cloud-based platform that hosts AI-driven insights.
Delivered in 5–7 business days
Receive your profile swiftly, with Radar gathering intelligence from thousands of data points.
24/7 monitoring for 12 months
Stay informed with continuous monitoring and live alerts, ensuring your profile is always up-to-date.
